Astera Labs
$350.33Change from previous close: −1.71%Absolute change: −$6.09
At a glance
- Revenue growth
- +115.13%
- 2025 vs 2024
- Net margin
- 25.7%
- 2024: -21.1%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | 1,532 | 1,055 | 196 | 212 |
| Current assets | 1,362 | 1,013 | 186 | 206 |
| Cash and equivalents | 168 | 79.6 | 45.1 | 76.1 |
| Short-term investments | 1,021 | 835 | 104 | 87.1 |
| Receivables | 83.2 | 38.8 | 8.3 | 10.7 |
| Inventory | 59.0 | 43.2 | 24.1 | 28.9 |
| Net property, plant and equipment | 115 | 38.6 | 7.6 | 3.5 |
| Current liabilities | 133 | 86.5 | 35.1 | 40.1 |
| Accounts payable | 42.4 | 26.9 | 6.3 | 10.3 |
| Total debt | 4.1 | 1.3 | 2.2 | 1.6 |
| Total liabilities | 168 | 89.7 | 38.9 | 41.9 |
| Total equity (incl. minority) | 1,364 | 965 | 157 | 170 |
| Retained earnings | 10.3 | -209 | -125 | -99.1 |